current glp 1 drugs How GLP-1 medications are transforming diabetes and weight loss treatment The GLP-1 Agonists and Obesity:
Description
Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, which mimics a hormone responsible for regulating appetite and stimulating insulin release
GLP-1 plays a key role in the occurrence and development of metabolic diseases such as obesity, nonalcoholic fatty liver disease, and atherosclerosis by regulating lipid metabolism
doi:10.1155/2024/8056440 Waldrop SW, Johnson VR, Stanford FC
& Elisaf, M
